ENTITY
Haw Par Corp

Haw Par Corp (HPAR SP)

42
Analysis
Health CareSingapore
Haw Par Corporation Limited is an investment holding company whose subsidiaries manufacture, market, and trade healthcare products under the Tiger and Kwan Loong brand names. The Company also manufactures dietary supplements and pharmaceuticals, and operates recreational centers. Haw Par invests in properties and securities.
more
Refresh
bullishHaw Par Corp
16 Nov 2022 10:08

2023 High Conviction: Haw Par Is Cheap

I like Haw Par here, and recommend going long outright or hedging against UOB (~58% of its NAV, 94% of its market cap). Singapore Land looks a lay...

Logo
857 Views
Share
bullishUOL Group
04 Mar 2024 14:00Exchange-sponsored

Director filings and buyback momentum return

Director filings and buyback momentum return Singapore Technologies Engineering (ST Engg) led the buyback consideration tally, repurchasing...

Share
bullishFirst REIT
08 Mar 2023 00:00Exchange-sponsored

Bright Spots in Singapore's Healthcare sector

The global Healthcare sector has expanded at a rapid pace over the recent years, driven by significant medical advances, accelerated drug approval...

Share
bullishHaw Par Corp
09 Feb 2023 15:58

Haw Par Corp Is Still Trading Cheap

I still like Haw Par here, and recommend going long outright or hedging against UOB (~58% of its NAV, 90% of its market cap).

Logo
566 Views
Share
bullishHaw Par Corp
06 Dec 2021 00:00Exchange-sponsored

20 Stocks with Most Net Insti Inflow Returned 32% YTD

The 20 stocks that have seen the highest net institutional inflows in the 2021 year to 3 Dec with combined net buying of S$2.8 billion,...

Share
x